Cargando…
Perspectives on pharmacologic strategies in the management of meningoencephalomyelitis of unknown origin in dogs
There are many non-infectious inflammatory diseases, assumed to be immune-mediated in origin, recognized to affect the nervous system in canine patients. Concentrating on meningoencephalomyelitis of unknown origin, we will discuss the medications used to treat the underlying disease process, focusin...
Autores principales: | Beasley, Michaela J., Shores, Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205981/ https://www.ncbi.nlm.nih.gov/pubmed/37234070 http://dx.doi.org/10.3389/fvets.2023.1167002 |
Ejemplares similares
-
Differential T-cell responses in dogs with meningoencephalomyelitis of unknown origin compared to healthy controls
por: Barber, Renee, et al.
Publicado: (2022) -
Treatment With Cytarabine at Initiation of Therapy With Cyclosporine and Glucocorticoids for Dogs With Meningoencephalomyelitis of Unknown Origin Is Not Associated With Improved Outcomes
por: Barber, Renee, et al.
Publicado: (2022) -
Meningoencephalomyelitis of Unknown Origin in Cats: A Case Series Describing Clinical and Pathological Findings
por: Nessler, Jasmin, et al.
Publicado: (2020) -
Case Report: Meningoencephalomyelitis of Unknown Etiology Manifesting as a Bilateral Cranial Polyneuropathy in 3 Dogs
por: Levitin, Hilary A., et al.
Publicado: (2020) -
New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: A review of 671 cases
por: Jeffery, Nick, et al.
Publicado: (2023)